Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-12-03T00:36:30.405Z Has data issue: false hasContentIssue false

Delirium After Gabapentin Withdrawal. Case Report

Published online by Cambridge University Press:  23 September 2014

Roberto Di Fabio
Affiliation:
University of Rome, Latina, Italy
Cecilia D’Agostino
Affiliation:
University of Rome, Rome, Italy
Giulio Baldi
Affiliation:
University of Rome, Rome, Italy
Francesco Pierelli
Affiliation:
Pozzilli (IS), Italy
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Canadian Journal of Neurological 2013

References

1. Mack, A. Examination of the evidence for off-label use of gabapentin. J Manag Care Pharm. 2003;9(6):559–68.Google ScholarPubMed
2. Norton, JW. Gabapentin withdrawal syndrome. Clin Neuropharmacol. 2001;24(4):245–6.CrossRefGoogle ScholarPubMed
3. Hellwig, TR, Hammerquist, R, Termaat, J. Withdrawal symptoms after gabapentin discontinuation. Am J Health Syst Pharm. 2010;67(11):910–2.CrossRefGoogle ScholarPubMed
4. Gee, NS, Brown, JP, Dissanayake, VUK, Offord, J, Thurlow, R, Woodruff, GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the a2d subunit of a calcium channel. J Biol Chem. 1996;271(10):5768–76.CrossRefGoogle Scholar
5. Uchitel, OD, Di Guilmi, MN, Urbano, FJ, Gonzalez-Inchauspe, C. Acute modulation of calcium currents and synaptic transmission by gabapentinoids. Channels (Austin). 2010;4(6):490–6.CrossRefGoogle ScholarPubMed